Combination of metagenomics and culture-based methods to study the interaction between ochratoxin a and gut microbiota

Toxicological Sciences

Volumn 141, Issue 1, 2014, Pages 314-323

  Guo, Mingzhang ^a   Huang, Kunlun ^a   Chen, Siyuan ^a   Qi, Xiaozhe ^a   He, Xiaoyun ^a   Cheng, Wen Hsing ^b   Luo, Yunbo ^a   Xia, Kai ^a   Xu, Wentao ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Gut microbiota; Lactobacillus; Metagenomics; Ochratoxin A

Indexed keywords

AMINO ACID TRANSPORTER; AMYLASE; ARABINOSE EFFLUX PERMEASE; ARGININE DECARBOXYLASE; BACTERIAL RNA; BETA N ACETYLHEXOSAMINIDASE; DIHYDROXYACETONE KINASE; DIPEPTIDASE; DNA HELICASE; ENDOGLUCANASE Y; GENOMIC DNA; GLYCOSIDASE; INTEGRASE; MISMATCH REPAIR PROTEIN; OCHRATOXIN; PEPTIDASE; PHOSPHOKETOLASE; PHOSPHOSERINE AMINOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE; PROTEINASE; RNA 16S; TRANSALDOLASE; TRANSPOSASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM; BACTEROIDES; CARBOHYDRATE TRANSPORT; CONTROLLED STUDY; DOREA; ESCHERICHIA; FECES ANALYSIS; INTESTINE FLORA; KIDNEY MASS; LACTOBACILLUS; LACTOBACILLUS PLANTARUM; MALE; METAGENOMICS; NEPHROTOXICITY; NONHUMAN; ORIBACTERIUM; RAT; RNA SEQUENCE; RUMINOCOCCUS; SIGNAL TRANSDUCTION; SYNTROPHOCOCCUS; THIN LAYER CHROMATOGRAPHY; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; FECES; FISCHER 344 RAT; GENETICS; INTESTINE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PROCEDURES;

LACTOBACILLUS;

ANIMALS; CHROMATOGRAPHY, THIN LAYER; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; INTESTINES; LACTOBACILLUS; MALE; METAGENOMICS; MICROBIOTA; OCHRATOXINS; RATS, INBRED F344; RNA, RIBOSOMAL, 16S;

EID: 84908371433     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfu128     Document Type: Article

References (44)

1. Abrunhosa, L., Santos, L. and Venâncio, A. (2006). Degradation of ochratoxin A by proteases and by a crude enzyme of Aspergillus niger. Food Biotechnol. 20, 231-242.
2. Ali-Vehmas, T., Rizzo, A., Westermarck, T. and Atroshi, F. (1998). Measurement of antibacterial activities of T-2 toxin, deoxynivalenol, ochratoxin A, aflatoxin B1 and fumonisin B1 using microtitration tray-based turbidimetric techniques. Zentralbl. Veterinarmed. A 45, 453-458.
3. Bisgaard, H., Li, N., Bonnelykke, K., Chawes, B. L., Skov, T., Paludan-Muller, G., Stokholm, J., Smith, B. and Krogfelt, K. A. (2011). Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 128, 646-652.
4. Boguhn, J., Neumann, D., Helm, A., Strobel, E., Tebbe, C. C., Danicke, S. and Rodehutscorda, M. (2010). Effects of concentrate proportion in the diet with or without Fusarium toxin-contaminated triticale on ruminal fermentation and the structural diversity of rumen microbial communities in vitro. Arch Anim. Nutr. 64, 467-483.
5. Chen, K. and Pachter, L. (2005). Bioinformatics for whole-genome shotgun sequencing ofmicrobial communities. PLoS Comput. Biol. 1, 106-112.
6. Consortium, T. H. M. P. (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
7. Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., Almeida, M., Quinquis, B., Levenez, F., Galleron, N., et al. (2013). Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588.
8. Creppy, E. E., Lugnier, A. A., Beck, G., Roschenthaler, R. and Dirheimer, G. (1979). Action of ochratoxin A on cultured hepatoma cells-reversion of inhibition by phenylalanine. FEBS Lett. 104, 287-290.
9. Dai, Q., Jue, Z., Qi, X., Xu, W., He, X., Guo, M., Dweep, H., Cheng, W., Luo, Y., Xia, K., et al. (2014). MicroRNA profiling of ratswith ochratoxin A nephrotoxicity. BMC Genomics 15, 333.
10. Del Prete, V., Rodriguez, H., Carrascosa, A. V., de las Rivas, B., Garcia-Moruno, E. and Munoz, R. (2007). In vitro removal of ochratoxin A by wine lactic acid bacteria. J. Food Prot. 70, 2155-2160.
11. Devaraj, S., Hemarajata, P. and Versalovic, J. (2013). The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clin. Chem. 59, 617-628
12. Fuchs, S., Sontag, G., Stidl, R., Ehrlich, V., Kundi, M. and Knasmuller, S. (2008). Detoxification of patulin and ochratoxin A, two abundantmycotoxins, by lactic acid bacteria. Food Chem. Toxicol. 46, 1398-1407.
13. Grenier, B. and Applegate, T. J. (2013). Modulation of intestinal functions following mycotoxin ingestion: Meta-analysis of published experiments in animals. Toxins (Basel) 5, 396-430.
14. Hammer, Ø., Harper, D. and Ryan, P. (2001). Past: Paleontological Statistics Software Package for education and data analysis. Paleontología Electrónica 4, 1-9.
15. Hwang, C. and Draughon, F. A. (1994). Degradation of ochratoxin A by Acinetobacter calcoaceticus. J. Food Prot. 57, 410-414.
16. Ismail, I. H., Oppedisano, F., Joseph, S. J., Boyle, R. J., Licciardi, P. V., Robins-Browne, R. M. and Tang, M. L. (2012). Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr. Allergy Immunol. 23, 674-681.
17. Karlsson, F. H., Fak, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Backhed, F. and Nielsen, J. (2012). Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, 1245-1252.
18. Kristiansson, E., Hugenholtz, P. and Dalevi, D. (2009). Shotgun-FunctionalizeR: An R-package for functional comparison of metagenomes. Bioinformatics 25, 2737-2738.
19. Looft, T., Johnson, T. A., Allen, H. K., Bayles, D. O., Alt, D. P., Stedtfeld, R. D., Sul, W. J., Stedtfeld, T. M., Chai, B., Cole, J. R., et al. (2012). In-feed antibiotic effects on the swine intestinal microbiome. Proc. Natl Acad. Sci. U.S.A. 09, 1691-1696.
20. Lozupone, C. A., Li, M., Campbell, T. B., Flores, S. C., Linderman, D., Gebert, M. J., Knight, R., Fontenot, A. P. and Palmer, B. E. (2013). Alterations in the gut microbiota associated with HIV-1 infection. Cell Host Microbe 14, 329-339.
21. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
22. Mantle, P. G., Nicholls, A. W. and Shockcor, J. P. (2011). H NMR spectroscopy-based metabolomic assessment of uremic toxicity, with toxicological outcomes, in male rats following an acute, mid-life insult fromochratoxin a. Toxins (Basel) 3, 504-519.
23. Marin-Kuan, M., Cavin, C., Delatour, T. and Schilter, B. (2008). Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 52, 195-202.
24. Ma, C., Wu, X., Nawaz, M., Li, J., Yu, P., Moore, J. E. and Xu, J. (2011). Molecular characterization of fecal microbiota in patients with viral diarrhea. Curr. Microbiol. 63, 259-266.
25. Mechoud, M. A., Juarez, G. E., de Valdez, G. F. and Rodriguez, A. V. (2012). Lactobacillus reuteri CRL 1098 and Lactobacillus acidophilus CRL 1014 differently reduce in vitro immunotoxic effect induced by Ochratoxin A. Food Chem. Toxicol. 50, 4310-4315.
26. NationalToxicologyProgram (1989). Toxicology and carcinogenesis Studies of ochratoxin A (CAS no. 303-47-9) in F344/N rats (gavage studies). Natl Toxicol. ProgramTech. Rep. Ser. 358, 1-142.
27. Nemoto, H., Kataoka, K., Ishikawa, H., Ikata, K., Arimochi, H., Iwasaki, T., Ohnishi, Y., Kuwahara, T. and Yasutomo, K. (2012). Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig. Dis. Sci. 57, 2955-2964.
28. Petchkongkaew, A., Taillandier, P., Gasaluck, P. and Lebrihi, A. (2008). Isolation of Bacillus spp. from Thai fermented soybean (Thua-nao): Screening for aflatoxin B1 and ochratoxin A detoxification. J. Appl. Microbiol. 104, 1495-1502.
29. Piotrowska, M. and Zakowska, Z. (2005). The elimination of ochratoxin A by lactic acid bacteria strains. Pol. J. Microbiol. 54, 279-286.
30. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60
31. Rodriguez, H., Reveron, I., Doria, F., Costantini, A., De Las Rivas, B., Munoz, R. and Garcia-Moruno, E. (2011). Degradation of ochratoxin a by Brevibacterium species. J. Agric. Food Chem 59, 10755-10760.
32. Schatzmayr, G., Zehner, F., Taubel, M., Schatzmayr, D., Klimitsch, A., Loibner, A. P. and Binder, E. M. (2006). Microbiologicals for deactivating mycotoxins. Mol. Nutr. Food Res. 50, 543-551.
33. Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009). Introducing mothur: Opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537-7541.
34. Shi, L., Liang, Z., Li, J., Hao, J., Xu, Y., Huang, K., Tian, J., He, X. and Xu,W. (2013). Ochratoxin A biocontrol and biodegradation by Bacillus subtilis CW 14. J. Sci. Food Agric.
35. Skrinjar, M., Rasic, J. L. and Stojicic, V. (1996). Lowering of ochratoxin A level in milk by yoghurt bacteria and bifidobacteria. Folia Microbiol. (Praha) 41, 26-28.
36. Stander, M. A., Bornscheuer, U. T., Henke, E. and Steyn, P. S. (2000). Screening of commercial hydrolases for the degradation of ochratoxin A. J. Agric. Food Chem. 48, 5736-5739.
37. Stoev, S. D., Djuvinov, D., Mirtcheva, T., Pavlov, D. and Mantle, P. (2002). Studies on some feed additives giving partial protection against ochratoxin A toxicity in chicks. Toxicol Lett. 135, 33-50.
38. Wache, Y. J., Valat, C., Postollec, G., Bougeard, S., Burel, C., Oswald, I. P. and Fravalo, P. (2009). Impact of deoxynivalenol on the intestinal microflora of pigs. Int. J. Mol. Sci. 10, 1-17.
39. Wang, M., Karlsson, C.,Olsson, C., Adlerberth, I.,Wold, A. E., Strachan, D. P., Martricardi, P. M., Aberg, N., Perkin, M. R., Tripodi, S., et al. (2008). Reduced diversity in the early fecal microbiota of infants with atopic eczema. J. Allergy Clin. Immunol. 121, 129-134.
40. Wegst, W. and Lingens, F. (1983). Bacterial degradation of ochratoxin A. FEMS Microbiol. Lett. 17, 341-344.
41. Woodmansey, E. J. (2007). Intestinal bacteria and ageing. J. Appl. Microbiol. 102, 1178-1186.
42. Zain,M. E. (2011). Impact ofmycotoxins on humans and animals. J. Saudi Chem. Soc. 15, 129-144.
43. Zanic-Grubisic, T., Zrinski, R., Cepelak, I., Petrik, J., Radic, B. and Pepeljnjak, S. (2000). Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine. Toxicol. Appl. Pharmacol. 167, 132-139.
44. Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., Li, M., Zhang, C., Zhang, Z., Zhang, Y., et al. (2012). Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 7, e42529.